Core Viewpoint - The A-share market shows positive momentum with the medical device sector performing actively, driven by significant developments in technology and policy support [1] Group 1: Market Performance - As of 14:03 on November 5, the three major A-share indices turned positive, with the medical device ETF (562600) rising by 1.11% [1] - The medical device sector has seen a net inflow of funds for five consecutive trading days, totaling 47 million [1] Group 2: Company Developments - Lepu Medical's self-developed rechargeable implantable deep brain stimulation device has received approval from the National Medical Products Administration, breaking the technological monopoly of international giants in the field of neuroregulation [1] - This approval is expected to provide new support for the company's performance growth [1] Group 3: Industry Insights - Huayuan Securities reports that the performance competition in the medical device sector has largely cleared up, with noticeable revenue recovery in equipment and consumables companies [1] - The sector is anticipated to benefit from policy support, particularly in cutting-edge technologies such as brain-computer interfaces and surgical robots, which may enter a revenue realization phase [1] - This could lead to a "Davis Double" effect, enhancing traditional business performance [1]